Preferred Pharmaceuticals, Inc. has recalled 144 bottles of Metformin HCl Extended Release Tablets (500 mg), a generic version of Glucophage XR. This recall was initiated because FDA testing found levels of N-Nitrosodimethylamine (NDMA) that exceed acceptable daily intake limits. NDMA is a substance that could increase the risk of cancer if people are exposed to it above acceptable levels over long periods of time. The affected 100-count bottles were distributed to two medical clinics in Florida.
The tablets contain NDMA levels that exceed the FDA's Acceptable Daily Intake Limit. NDMA is classified as a probable human carcinogen, meaning long-term exposure to levels above the safety limit may increase the risk of developing cancer.
Healthcare consultation and product return for refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.